IKK-16 | Interleukin Related interleukin-related.com

Product Name :
IKK-16

Search keywords :
IKK 16

drugId :
null

Target Vo:
Glycogen synthase kinase-3

Target Vo Short Name :
GSK3

Moa_Name:
Glycogen synthase kinase-3 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
University Of North Carolina At Chapel Hill

Active Company_Name :
University Of North Carolina At Chapel Hill

Active Indication_Name:
Malaria

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Tarextumab site
APC6 Rabbit mAb Data Sheet
TNF Receptor 2 Antibody: TNF Receptor 2 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 48 kDa, targeting to TNF Receptor 2. It can be used for WB,IHC-F,IHC-P,ICC/IF,FC,IP assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts